Transcatheter aortic valve replacement: game-changing innovation for patients with aortic stenosis.
Annu Rev Med
; 65: 367-83, 2014.
Article
en En
| MEDLINE
| ID: mdl-24160938
ABSTRACT
Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in 2002, TAVR has made remarkable progress in the past decade with completion of major randomized clinical trials, multiple observational registries, and evolution of several new devices. This article is a brief introductory overview of the TAVR procedure, devices, trials and registries, and newer developments in the field.
Texto completo:
1
Ejes tematicos:
Pesquisa_clinica
Banco de datos:
MEDLINE
Asunto principal:
Válvula Aórtica
/
Estenosis de la Válvula Aórtica
/
Prótesis Valvulares Cardíacas
/
Cateterismo Cardíaco
/
Implantación de Prótesis de Válvulas Cardíacas
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Año:
2014
Tipo del documento:
Article